The use of clozapine among individuals with intellectual disability: A review

Research in Developmental Disabilities

Volumn 31, Issue 6, 2010, Pages 1135-1141

  Singh, Ashvind N ^a   Matson, Johnny L ^a   Hill, B D ^a   Pella, Russell D ^a   Cooper, Christopher L ^a   Adkins, Angela D ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Behavior problems; Clozapine; Intellectual disabilities; Medication; Treatment

Indexed keywords

CLOZAPINE; PLACEBO;

AGGRESSIVENESS; AGITATION; BEHAVIOR CHANGE; BEHAVIOR DISORDER; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COGNITION; CONSTIPATION; DROWSINESS; DRUG APPROVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSKINESIA; EPILEPSY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERSALIVATION; HYPOTENSION; INCONTINENCE; INTELLECTUAL IMPAIRMENT; LEUKOPENIA; MEDLINE; MENTAL INSTABILITY; NEUTROPENIA; PSYCHOPHARMACOLOGY; PSYCINFO; QUALITY OF LIFE; REVIEW; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SEDATION; SEIZURE; SIDE EFFECT; SOCIAL BEHAVIOR; TACHYCARDIA; UNITED STATES; URINARY FREQUENCY; VOMITING; WEIGHT GAIN;

ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; MENTAL DISORDERS; MENTAL RETARDATION;

EID: 77957122861     PISSN: 08914222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ridd.2010.07.003     Document Type: Review

References (34)

1. Aman M.G., Singh N.N. The usefulness of thioridazine for treating childhood disorders: Fact or folklore?. American Journal of Mental Deficiency 1980, 84:331-338.
2. Antonacci D.J., de Groot J. Clozapine treatment in a population of adults with mental retardation. Journal of Clinical Psychiatry 2000, 61:22-25.
3. Buzan R.D., Dubovsky S.L., Firestone D., Dal Pozzo E. Use of clozapine in 10 mentally retarded adults. Journal of Neuropsychiatry 1998, 10:93-95.
4. Cohen S.A., Underwood M.T. The use of clozapine in a mentally retarded and aggressive population. Journal of Clinical Psychiatry 1994, 55:440-444.
5. deLeon J., Greenlee B., Barber J., Sabaawi M., Singh N.N. Practice guidelines for the use of new generation antipsychotic drugs (except clozapine) in adult individuals with intellectual disabilities. Research in Developmental Disabilities 2009, 30:613-669.
6. Hammock R.G., Schroeder S.R., Levine W.R. The effect of clozapine on self-injurious behavior. Journal of Autism and Developmental Disorders 1995, 25:611-626.
7. Hammock R., Levine W.R., Schroeder S.R. Brief report: Effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation. Journal of Autism and Developmental Disorders 2001, 31:109-113.
8. Hodapp R.M., Dykens E.M. Mental retardation (intellectual disabilities). Child psychopathology 2003, 486-519. The Guilford Press, NY. 2nd ed. E.J. Mash, R.A. Barkley (Eds.).
9. Holden B., Gitlesen J.P. The overlap between psychiatric symptoms and challenging behaviour: A preliminary study. Research in Developmental Disabilities 2009, 30:210-218.
10. Intagliata J., Rinck M.A. Psychoactive drug use in public and community residential facilities for mentally retarded persons. Psychopharmacology Bulletin 1985, 21:268-278.
11. Kamal M., Kelly M. The use of clozapine in an individual with moderate intellectual disability, aggressive behavior and resistant psychosis. Journal of Psychological Medicine 1999, 16:32-33.
12. Kane J.M. Clinical efficacy of clozapine in treatment-refractory schizophrenia: An overview. British Journal of Psychiatry 1992, 160(Suppl. 17):41-45.
13. Matson J.L., Neal D. Psychotropic medication use for challenging behaviors in persons with intellectual disabilities: An overview. Research in Developmental Disabilities 2009, 30:572-586.
14. Matson J.L., Shoemaker M. Intellectual disability and its relationship to autism spectrum disorders. Research in Developmental Disabilities 2009, 30:1107-1114.
15. Matson J.L., Mayville E.A., Bielecki J., Barnes W.H., Bamburg J.W., Baglio C.S. Reliability of the Matson evaluation of drug side effects scale (MEDS). Research in Developmental Disabilities 1998, 19:501-506.
16. Matson J.L., Bamburg J.W., Mayville E.A., Pinkston J., Bielecki J., Kuhn D., et al. Psychopharmacology and mental retardation: A 10 year review (1990-1999). Research in Developmental Disabilities 2000, 21:263-296.
17. Maxmen J.S., Kennedy S.H., McIntyre R.S. Psychotropic drug fast facts 2008, W. W. Norton & Company, NY. 4th ed.
18. Pary R.J. Clozapine in three individuals with mild mental retardation and treatment refractory psychiatric disorders. Mental Retardation 1994, 32:323-327.
19. Ratey J.J., Leveroni C., Kilmer D., Gutheil C., Swartz B. The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital. Journal of Clinical Psychiatry 1993, 54:219-223.
20. Sajatovic M., Ramirez L.F., Kenny J.T., Meltzer H.Y. The use of clozapine in borderline-intellectual-functioning and mentally retarded schizophrenic patients. Comprehensive Psychiatry 1994, 35:29-33.
21. 2 dopamine modulating drugs and self-injury in mental retardation and developmental disability. Mental Retardation and Developmental Disabilities Research News 1995, 1:120-129.
22. Shoji H., Kaizumi N., Ozaki H. Linguistic lateralization in adolescents with Down Syndrome revealed by a dichotic monitoring test. Research in Developmental Disabilities 2009, 30:219-228.
23. Singh A.N., Matson J.L. An examination of psychotropic medication prescription practices for individuals with intellectual disabilities. Journal of Developmental and Physical Disabilities 2009, 21:115-119.
24. Singh A.N., Matson J.L., Cooper C.L., Dixon D., Sturmey P. The use of risperidone among individuals with mental retardation: Clinically supported or not?. Research in Developmental Disabilities 2005, 26:203-218.
25. Soenen S., Berckelaer-Onnes I.V., Scholte E. Patterns of intellectual, adaptive and behavioral functioning in individuals with mild mental retardation. Research in Developmental Disabilities 2009, 30:433-444.
26. Sprague R.L., Werry J.S. Methodology of psychopharmacological studies with the retarded. International Review of Research in Mental Retardation 1971, 147-219. Academic Press, New York. N.R. Ellis (Ed.).
27. Thalayasingam S., Alexander R.T., Singh I. The use of clozapine in adults with intellectual disability. Journal of Intellectual Disability Research 2004, 28:572-579.
28. Thuresson K., Farnstrand M. A follow-up of medical treatment of persons with psychiatric health problems and mental retardation. Nordic Journal of Psychiatry 1999, 53:127-130.
29. Van der Molen J.J., Van Luit J.E.H., Jongmans M.J., Van der Molen M.W. Memory profiles with mild intellectual disabilities: Strengths and weaknesses. Research in Developmental Disabilities 2009, 30:1237-1247.
30. VlasKamp C., van der Putten A. Focus on interaction: The use of an individualized support program for persons with profound intellectual and multiple disabilities. Research in Developmental Disabilities 2009, 30:873-883.
31. Vyncke J. The treatment of behavior disorders in idiocy and imbecility with clozapine. Pharmakopsychiatry and Neuropsychopharmakology 1974, 7:225-229.
32. Weiss J.A., Lunsky Y., Tassé M.J., Durbin J. Support for the construct validity of the Supports Intensity Scale based on clinical ranking of need. Research in Developmental Disabilities 2009, 30:933-941.
33. Williams D.E., Kirkpatrick-Sanchez S., Crocker W.T., Raichman J.A., Rochen S., Horany M., et al. An evaluation of clozapine combined with behavioral intervention in the treatment of aggression and tantrums in a woman with mental retardation and schizophrenia. Journal of Developmental and Physical Disabilities 1995, 7:155-160.
34. Yen C.F., Lin J.D., Loh C.H., Shi L., Hsu S.W. Determinants of prescription drug use by adolescents with intellectual disabilities in Taiwan. Research in Developmental Disabilities 2009, 30:1354-1366.